Bilirubin encephalopathy: A study of neuronal subpopulations and neurodegenerative mechanisms in 12 autopsy cases

Brain and Development

Volumn 30, Issue 4, 2008, Pages 269-278

  Hachiya, Yasuo ^a   Hayashi, Masaharu ^b  

^a Tokyo Metropolitan Fuchu Medical Center for the Disabled   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Basal ganglia; Bilirubin encephalopathy; Kernicterus; Neuropathology; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CALBINDIN; CALRETININ; ENKEPHALIN; METHIONINE; NEUROTRANSMITTER; PARVALBUMIN; SUBSTANCE P; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ADULT; ARTICLE; AUTOPSY; BASAL GANGLION; BRAIN DEGENERATION; BRAIN NERVE CELL; CELL NUCLEUS; CELL SUBPOPULATION; CHILD; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERNICTERUS; MALE; NEUROTRANSMITTER RELEASE; NEWBORN; NEWBORN JAUNDICE; OXIDATIVE STRESS; PUTAMEN;

ADOLESCENT; ADULT; CALCIUM-BINDING PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; KERNICTERUS; MALE; NERVE DEGENERATION; NEUROPEPTIDES; OXIDATIVE STRESS; PUTAMEN; SUBSTANTIA NIGRA; THALAMUS; TYROSINE 3-MONOOXYGENASE;

EID: 40249089895     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2007.08.013     Document Type: Article

References (22)

1. Volpe J.J. Bilirubin and brain injury. Neurology of the newborn. 4th ed. (2001), Saunders, Philadelphia 521-546
2. Friede R.L. Kernicterus (Bilirubin encephalopathy). Developmental neuropathology. 2nd ed. (1989), Springer-Verlag, Berlin 113-124
3. Kinney H.C., and Armstrong D.D. Perinatal neuropathology. In: Graham D.I., and Lantos P.L. (Eds). Greenfield's neuropathology. 6th ed. (2002), Arnold, London 519-606
4. Hansen T.W. Bilirubin brain toxicity. J Perinatol 21 Suppl. 1 (2001) 48-51
5. Shapiro S.M. Bilirubin toxicity in the developing nervous system. Pediatr Neurol 29 (2003) 410-421
6. Falcão A.S., Fernandes A., Brito M.A., Silva R.F.M., and Brites D. Bilirubin-induced immunostimulant effects and toxicity vary with neural cell type and maturation state. Acta Neuropathol 112 (2006) 95-105
7. Hayashi M., Araki S., Kohyama J., Shioda K., Fukatsu R., and Tamagawa K. Brainstem and basal ganglia lesions in xeroderma pigmentosum group A. J Neuropathol Exp Neurol 63 (2004) 1048-1057
8. Hayashi M., Araki S., Kohyama J., Shioda K., and Fukatsu R. Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Dev 27 (2005) 34-38
9. Hayashi M., Itoh M., Araki S., Kumada S., Shioda K., Tamagawa K., et al. Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders. J Neuropathol Exp Neurol 60 (2001) 350-356
10. Hedreen J.C. Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus. J Comp Neurol 409 (1999) 400-410
11. Prensa L., Cossette M., and Parent A. Dopaminergic innervation of human basal ganglia. Chem Neuroanat 20 (2000) 207-213
12. Brana C., Charron G., Aubert I., Carles D., Martin-Negrier M.L., Trouette H., et al. Ontogeny of the striatal neurons expressing neuropeptide genes in the human fetus and neonate. J Comp Neurol 360 (1995) 488-505
13. Nakano K., Katayama T., Tsutsumi T., and Ushio H. Neural circuits and functional organization of the striatum. J Neurol 247 Suppl. 5 (2000) 1-15
14. Cicchetti F., Prensa L., Wu Y., and Parent A. Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease. Brain Res Rev 34 (2000) 80-101
15. Morel A., Loup F., Magnin M., and Jeanmonod D. Neurochemical organization of the human basal ganglia: anatomofunctional territories defined by the distributions of calcium-binding proteins and SMI-32. J Comp Neurol 443 (2002) 86-103
16. Kalanithi P.S., Zheng W., Kataoka Y., DiFiglia M., Grantz H., Saper C.B., et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci USA 102 (2005) 13307-13312
17. Johnston M.V., and Hoon A.H. Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol 15 (2000) 588-591
18. McDonald J.W., Shapiro S.M., Silverstein F.S., and Johnston M.V. Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model. Exp Neurol 150 (1998) 21-29
19. Jellinger K.A. General aspects of neurodegeneration. J Neural Transm Suppl 65 (2003) 101-144
20. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60 (2001) 759-767
21. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 53 Suppl. 3 (2003) 26-38
22. Toyokuni S., Tanaka T., Hattori Y., Nishiyama Y., Yoshida A., Uchida K., et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76 (1997) 365-374